A soluble form of IL-13 receptor α1 promotes IgG2a and IgG2b production by murine germinal center B cells

Journal of Immunology

Volumn 163, Issue 3, 1999, Pages 1153-1161

  Poudrier, Johanne ^a   Graber, Pierre ^a   Herren, Suzanne ^a   Gretener, Denise ^a   Elson, Greg ^a,b   Berney, Claude ^a   Gauchat, Jean François ^a,b   Kosco Vilbois, Marie H ^a  

^a SERONO PHARMACEUTICAL RES INSTITUTE   (Switzerland)

^b Centre d'Immunologie Pierre Fabre   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CD40 ANTIGEN; CELL SURFACE PROTEIN; IMMUNOGLOBULIN G2A; IMMUNOGLOBULIN G2B; INTERLEUKIN 13 RECEPTOR; INTERLEUKIN 13 RECEPTOR ALPHA1; INTERLEUKIN 4 RECEPTOR; LIGAND; MONOCLONAL ANTIBODY; RECEPTOR SUBTYPE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; B LYMPHOCYTE; B LYMPHOCYTE DIFFERENTIATION; CELL ISOLATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; GERMINAL CENTER; IMMUNOGLOBULIN PRODUCTION; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; B-LYMPHOCYTES; BASE SEQUENCE; CELLS, CULTURED; FEMALE; GERMINAL CENTER; IMMUNE TOLERANCE; IMMUNOGLOBULIN G; IMMUNOGLOBULIN ISOTYPES; INJECTIONS, SUBCUTANEOUS; INTERLEUKIN-13; INTERLEUKIN-13 RECEPTOR ALPHA1 SUBUNIT; INTERLEUKIN-6; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, KNOCKOUT; MOLECULAR SEQUENCE DATA; RECEPTORS, INTERLEUKIN; RECEPTORS, INTERLEUKIN-13; SOLUBILITY;

EID: 0033178738     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (58)

1. Minty, A., P. Chalon, J. M. Derocq, X. Dumont, J. C. Guillemot, M. Kaghad, C. Labil, P. Leplatois, P. Liauzun, B. Miloux, et al. 1993. Interleukin-13 is a new human lymphokine regulating inflammatory and immune responses. Nature 362: 248.
2. Zurawski, S. M., F. J. Vega, B. Huyghe, and G. Zurawski. 1993. Receptors for interleukin-13 and interleukin-4 are complex and share a novel component that functions in signal transduction. EMBO J. 12:2663.
3. Zurawski, G., and J. E. de Vries. 1994. Interleukin 13, an interleukin 4-like cytokine that acts on monocytes and B cells, but not on T cells. Immunol. Today 15:19.
4. Chomarat, P., and J. Bancherau. 1997. An update on interleukin-4 and its receptor. Eur. Cytokine Network 8:333.
5. deWaal Malefyt, R., C.G. Figdor, R. Huijbens, S. Mohan-Peterson, B. Bennett, J. Culpepper, W. Dang, G. Zurawski, and J. E. de Vries. 1993. Effects of IL-13 on phenotype, cytokine production, and cytotoxic function of human monocytes: comparison with IL-4 and modulation by IFN-γ or IL-10. J. Immunol. 151:6370.
6. Andersson, A., S. M. Grunewald, A. Duschl, A. Fischer, and J. P. DiSanto. 1997. Mouse macrophage development in the absence of the common γ chain: defining receptor complexes responsible for IL-4 and IL-13 signaling. Eur. J. Immunol. 27:1762.
7. Doherty, T. M., R. Kastelein, S. Menon, S. Andrade, and R. L. Coffman. 1993. Modulation of murine macrophage function by IL-13. J. Immunol 151:7151.
8. Jacobsen, S. E. W., C. Okkenhaug, O. P. Veiby, D. Caput, P. Ferrara, and A. Minty. 1994. Interleukin 13: novel role in direct regulation of proliferation and differentiation of primitive hematopoietic progenitor cells. J. Exp. Med. 180:75.
9. Nicoletti, F., G. Mancuso, V. Cusumano, R. DiMarco, P. Zaccone, K. Bendtzen, and G. Teti. 1997. Prevention of endotoxin-induced lethality in neonatal mice by interleukin-13. Eur. J. Immunol. 27:1580.
10. Lebman, D. A., and R. L. Coffman. 1988. Interleukin 4 causes isotype switching to IgE in T cell-stimulated clonal B cell cultures. J. Exp. Med. 168:853.
11. Pene, J., F. Rousset, F. Briere, I. Chretien, J. Y. Bonnefoy, H. Spits, T. Yokota, N. Arai, K. Arai, J. Banchereau, et al. 1988. IgE production by normal human lymphocytes is induced by interleukin 4 and suppressed by interferons γ and α and prostaglandin E2. Proc. Natl. Acad. Sci. USA 85:6880.
12. Punnonen, J., G. Aversa, B. G. Cocks, A. N. McKenzie, S. Menon, G. Zurawski, R. de Waal Malefyt, and J. E. de Vries. 1993. Interleukin 13 induces interleukin 4-independent IgG4 and IgE synthesis and CD23 expression by human B cells. Proc. Natl. Acad. Sci. USA 90:3730.
13. Defrance, T., P. Carayon, G. Billian, J. C. Guillemot, A. Minty, D. Caput, and P. Ferrara. 1994. Interleukin 13 is a B cell stimulating factor. J. Exp. Med. 179: 135.
14. McKenzie, A. N., J. A. Culpepper, R. de Waal Malefyt, F. Briere, J. Punnonen, G. Aversa, A. Sato, W. Dang, B. G. Cocks, S. Menon, et al. 1993. Interleukin 13, a T-cell-derived cytokine that regulates human monocyte and B-cell function. Proc. Natl. Acad. Sci. USA 90:3735.
15. Welham, M. J., L. Learmonth, H. Bone, and J. W. Schrader. 1995. Interleukin-13 signal transduction in lymphohemopoietic cells: similarities and differences in signal transduction with interleukin-4 and insulin. J. Biol. Chem. 270:12286.
16. Orchansky, P., S. D. Ayres, D. J. Hilton, and J. W. Schrader. 1997. An interleukin (IL)-13 receptor lacking the cytoplasmic domain fails to transduce IL-13-induced signals and inhibits responses to IL-4. J. Biol. Chem. 272:22940.
17. Hilton, D. J., J. G. Zhang, D. Metcalf, W. S. Alexander, N. A. Nicola, and T. A. Willson. 1996. Cloning and characterization of a binding subunit of the interleukin 13 receptor that is also a component of the interleukin 4 receptor. Proc. Natl. Acad. Sci. USA 93:497.
18. Caput, D., P. Laurent, M. Kaghad, J. M. Lelias, S. Lefort, N. Vita, and P. Ferrara. 1996. Cloning and characterization of a specific interleukin (IL)-13 binding protein structurally related to the IL-5 receptor α chain. J. Biol. Chem. 271:16921.
19. Aman, M. J., N. Tayebi, N. I. Obiri, R. K. Puri, W. S. Modi, and W. J. Leonard. 1996. cDNA cloning and characterization of the human interleukin 13 receptor α chain. J. Biol. Chem. 271:29265.
20. Miloux, B., P. Laurent, O. Bonnin, J. Lupker, D. Caput, N. Vita, and P. Ferrara. 1997. Cloning of the human IL-13Rα1 chain and reconstitution with the IL4Rα of a functional IL-4/IL-13 receptor complex. FEBS Lett. 401:163.
21. Gauchat, J.-F., E. Schlagenhauf, N. P. Feng, R. Moser, M. Yamage, P. Jeannin, S. Alouani, G. Elson, L. D. Notarangelo, T. Wells, et al. 1997. A novel 4-kb interleukin-13 receptor α mRNA expressed in human B, T, and endothelial cells encoding an alternate type-II interleukin-4/interleukin-13 receptor. Eur. J. Immunol. 27:971.
22. Zhang, J. G., D. J. Hilton, T. A. Willson, C. McFarlane, B. A. Roberts, R. L. Moritz, R. J. Simpson, W. S. Alexander, D. Metcalf, and N. A. Nicola. 1997. Identification, purification, and characterization of a soluble interleukin (IL)-13-binding protein: evidence that it is distinct from the cloned Il-13 receptor and Il-4 receptor α-chains. J. Biol. Chem. 272:9474.
23. Donaldson, D. D., M. J. Whitters, L. J. Fitz, T. Y. Neben, H. Finnerty, S. L. Henderson, R. M. O'Hara, Jr., D. R. Beier, K. J. Turner, C. R. Wood, et al. 1998. The murine IL-13 receptor α2: molecular cloning, characterization, and comparison with murine IL-13 receptor α1. J. Immunol 161:2317.
24. Bazan, J. F. 1990. Structural design and molecular evolution of a cytokine receptor superfamily. Proc. Natl. Acad. Sci. USA 87:6934.
25. Tanner, W. J., W. Chen, R. L. Young, G. D. Longmore, and A. S. Shaw. 1995. The conserved boxl motif of cytokine receptors is required for association with JAK kinases. J. Biol. Chem. 270:6523.
26. Stahl, N., T. J. Farruggella, T. G. Boulton, Z. Zhong, J. E. Darnell, Jr., and G. D. Yancopoulos. 1995. Choice of STATs and other substrates specified by modular tyrosine-based motifs in cytokine receptors. Science 267:1349.
27. MacLennan, I. C. 1994. Germinal centers. Annu. Rev. Immunol. 12:117.
28. Kosco-Vilbois, M., J.-Y. Bonnefoy, and Y. Chvatchko. 1997. The physiology of murine germinal center reactions. Immunol. Rev. 156:127.
29. Kosco-Vilbois, M., and H. G. J. a. B. J. Y. Zentgraf. 1997. To "B" or not to "B" a germinal center? Immunol. Today 18:225.
30. Gray, D., S. Bergthorsdottir, D. vanEssen, M. Wykes, J. Poudrier, and K. Siepmann. 1997. Observations on memory B-cell development. Semin. Immunol. 9:249.
31. Kawabe, T., T. Naka, K. Yoshida, T. Tanaka, H. Fujiwara, S. Suematsu, N. Yoshida, T. Kishimoto, and H. Kikutani. 1994. The immune responses in CD40-deficient mice: impaired immunoglobulin class switching and germinal center formation. Immunity 1:167.
32. Xu, J., T. M. Foy, J. D. Laman, E. A. Elliot, J. J. Dunn, T. J. Waldschmidt, J. Elsemore, R. J. Noelle, and R. A. Flavell. 1994. Mice deficient for CD40 ligand. Immunity 1:423 (Abstr.).
33. Grewal, I. S., J. Xu, and R. A. Flavell. 1995. Impairment of antigen-specific T-cell priming in mice lacking CD40 ligand. Nature 378:617.
34. Clark, E. A., and J.A. Ledbetter. 1994. How B and T cells talk to each other. Nature 367:425.
35. Graber, P., D. Gretener, S. Herren, J.-P. Aubry, G. Elson, J. Poudrier, S. Lecoanet-Henchoz, C. Alouani, C. Losberger, J.-Y. Bonnefoy, et al. 1998. The distribution of IL-13R1 expression by B cells, T cells and monocytes and its regulation by IL-13 and IL-4. Eur. J. Immunol. 28:4286.
36. deVries, J. E., and G. Zurawski. 1995. Immunoregulatory properties of IL-13: its potential role in atopic disease. Int.l Arch. Allergy Immunol. 106:175.
37. Gray, D., M. Kosco, and B. Stockinger. 1991. Novel pathways of antigen presentation for the maintenance of memory. Int. Immunol. 3:141.
38. Kopf, M., H. Baumann, G. Freer, M. Freudenberg, M. Lamers, T. Kishimoto, R. Zinkernagel, H. Bluethmann, and G. Kohler. 1994. Impaired immune and acute-phase responses in interleukin-6-deficient mice. Nature 368:339.
39. Mazzei, G. J., M. D. Edgerton, C. Losberger, S. Lecoanet-Henchoz, P. Graber, A. Durandy, J. F. Gauchat, A. Bernard, B. Allet, and J. Y. Bonnefoy. 1995. Recombinant soluble trimeric CD40 ligand is biologically active. J. Biol. Chem. 270:7025.
40. Keller, G., M. Kennedy, T. Papayannopoulou, and M.V. Wiles. 1993. Hematopoietic commitment during embryonic stem cell differentiation in culture. Mol. Cell. Biol. 13:473.
41. Johansson, B. M., and M. V. Wiles. 1995. Evidence for involvement of activin a and bone morphogenetic protein 4 in mammalian mesoderm and hematopoietic development. Mol. Cell. Biol. 15:141.
42. Aubry, J. P., N. Dugas, S. Lecoanet-Henchoz, F. Ouaaz, H. Zhao, J. F. Delfraissy, P. Graber, J. P. Kolb, B. Dugas, and J. Y. Bonnefoy. 1997. The 25-kDa soluble CD23 activates type III constitutive nitric oxide-synthase activity via CD11b and CD11c expressed by human monocytes. J. Immunol. 159:614.
43. Kosco, M. H., E. Pflugfelder, and D. Gray. 1992. Follicular dendritic cell-dependent adhesion and proliferation of B cells in vitro. J. Immunol. 148:2331.
44. Callard, R. E., D. J. Matthews, and L. Hibbert. 1996. IL-4 and IL-13 receptors: are they one and the same? Immunol. Today 17:108.
45. Kopf, M., S. Herren, M. V. Wiles, M. B. Pepys, and M. H. Kosco-Vilbois. 1998. Interleukin 6 influences germinal center development and antibody production via a contribution of C3 complement component. J. Exp. Med. 000:000
46. Taga, T., and T. Kishimoto. 1997. gp130 and the interleukin-6 family of cytokines. Annu. Rev. Immunol. 15:797.
47. Fukada, T., M. Hibi, Y. Yamanaka, M. Takahashi-Tezuka, Y. Fujitani, T. Yamaguchi, K. Nakajima, and T. Hirano. 1996. Two signals are necessary for cell proliferation induced by a cytokine receptor gp130: involvement of STAT3 in anti-apoptosis. Cell 5:449.
48. Akira, S., K. Yoshida, T. Tanaka, T. Taga, and T. Kishimoto. 1995. Targeted disruption of the IL-6 related genes: gp130 and NF-IL-6. Immunol. Rev. 148:221.
49. Ogata, H., D. Ford, N. Kouttab, T. C. King, N. Vita, A. Minty, J. Stoeckler, D. Morgan, C. Girasole, J. W. Morgan, et al. 1998. Regulation of interleukin-13 receptor constituents on mature human B lymphocytes. J. Biol. Chem. 273:9864.
50. Barrier, M., M. Mohrs, F. Brombacher, and M. Kopf. 1998. Differences between IL-4Ra-deficient and IL-4-deficient mice reveal a role for IL-13 in the regulation of Th2 responses. Curr. Biol. 8:669.
51. Bancroft, A. J., A. N. J. Mckenzie, and R. K. Grencis. 1998. A critical role for IL-13 in resistance to intestinal nematode infection. J. Immunol. 160:3453.
52. Urban, J. F., Jr., N. Noben-Trauth, D. D. Donaldson, K. B. Madden, S. C. Morris, M. Collins, and F.D. Finkelman. 1998. IL-13, Il-4Ra, and STAT6 are required for the expulsion of the gastrointestinal nematode parasite Nippostrongylus brasiliensis. Immunity 8:255.
53. McKenzie, G. J., A. Bancroft, R. K. Grencis, and A. N. J. Mckenzie. 1998. A distinct role for interleukin-13 in Th2-cell-mediated immune responses. Curr. Biol. 8:339.
54. Morse, L., D. Chen, D. Franklin, Y. Xiong, and S. Chen-Kiang. 1997. Induction of cell cycle arrest and B cell terminal differentiation by cdk inhibitor p18(ink4c) and IL-6. Immunity 6:47.
55. Lai, Y. H., J. M. Heslan, S. Poppema, J. F. Elliot, and T. R. Mosmann. 1996. Continuous administration of IL-13 to mice induces extramedullary hemopoiesis and monocytosis. J. Immunol. 156:3166.
56. DiSanto, E., C. Meazza, M. Sironi, P. Fruscella, A. Mantovani, J. D. Sipe, and P. Ghezzi. 1997. IL-13 inhibits TNF production but potentiates that of IL-6 in vivo and ex vivo in mice. J. Immunol. 159:379.
57. Sironi, M., F. L. Sciacca, C. Matteucci, M. Conni, A. Vecchi, S. Bernasconi, A. Minty, D. Caput, P. Ferrara, F. Colotta, et al. 1994. Regulation of endothelial and mesothelial cell function by interleukin-13: selective induction of vascular cell adhesion molecule-1 and amplification of interleukin-6 production. Blood 84:1913.
58. Derocq, J.-M., M. Segui, C. Püoinol-Chazel, A. Minty, D. Caput, P. Ferrara, and P. Casellas. 1994. Interleukin-13 stimulates interleukin-6 production by human keratinocytes: similarity with interleukin-4. FEBS Lett. 343:32.